Scleroderma Research

Patients With Scleroderma Wanted for Clinical Trial

We have been contacted by a pharmaceutical company to help recruit patients for a clinical trial being conducted in patients with Raynaud’s phenomenon secondary to scleroderma/systemic sclerosis. The study medication is a topical cream that will be applied to the hand. Participation will require travel to a clinical site.   The first site is in Encinitas,

2015-04-03T19:23:33-04:00November 17th, 2014|In The News|Comments Off on Patients With Scleroderma Wanted for Clinical Trial

New Jersey Presentation on Clinical Trials

Dr. Vivien Hsu, Medical Director of Clinical Research Center at Robert Wood Johnson Medical School, will be speaking about upcoming clinical trials for scleroderma and Raynaud’s phenomenon patients on Saturday, November 13, 2010 1:00-3:00 p.m. at the Hackensack University Medical Center in New Jersey.

2010-11-11T23:16:21-05:00October 2nd, 2010|In The News|2 Comments
Go to Top